share_log

Ladenburg Thalmann Upgrades Forte Biosciences to Buy, Announces $2.75 Price Target

Ladenburg Thalmann Upgrades Forte Biosciences to Buy, Announces $2.75 Price Target

拉登堡塔爾曼將Forte Biosciences上調至收購,宣佈2.75美元的目標股價
Benzinga ·  04/09 05:36

Ladenburg Thalmann analyst Michael Higgins upgrades Forte Biosciences (NASDAQ:FBRX) from Neutral to Buy and announces $2.75 price target.

拉登堡塔爾曼分析師邁克爾·希金斯將Forte Biosciences(納斯達克股票代碼:FBRX)從中性上調至買入,並宣佈了2.75美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論